![40 years in Interventional Radiology](/media/upvjiwaj/40years-banner-1920x650-nologo.jpg?center=0.76619816212518976,0.89157199071458559&mode=crop&width=1920&height=650&rnd=132932810292200000)
They tell us about their experience with Lipiodol®
in Interventional Radiology
![Prof. Thierry De Baere](/media/mtrlo4ym/prof-thierry-de-baere.jpg?center=0.38824368144285559,0.63566360115673715&mode=crop&width=512&height=288&rnd=133045326228870000)
Prof Thierry de Baere
The beginning of my journey with Lipiodol®.
![Dr David Benz (1)](/media/hi2aav3m/dr-david-benz.png?anchor=center&mode=crop&width=512&height=288&rnd=133045324736470000)
Dr David Benz
Discover his experience from Switzerland to Australia.
Watch THE FULL VIDEO
![Dr Yasuaki Arai (1)](/media/zsyojb25/dr-yasuaki-arai.png?center=0.73185420996214023,0.33061366634348771&mode=crop&width=512&height=288&rnd=133021088848930000)
Dr Yasuaki Arai
Shares his experience on getting cTACE approved for Japan which lead to worldwide approval.
Watch THE FULL VIDEO
![Dr Aisaku Fukuda (1)](/media/4rinuk2b/dr-aisaku-fukuda.png?center=0.13851838943328107,0.38826666666666665&mode=crop&width=512&height=288&rnd=133107286331870000)
Dr Aisaku Fukuda
On why he still uses Lipiodol® after 45 year! HSG Focused.
![Dr Simon Yu (1)](/media/g2lngbbd/dr-simon-yu.png?center=0.75715630016502167,0.45629633126048663&mode=crop&width=512&height=288&rnd=133045236191800000)
Dr Simon Yu
Shares his passion on research and education, and why he appreciates Lipiodol®.
Watch THE FULL VIDEO
![Dr Richard Waugh](/media/k2rdmi3l/dr-richard-waugh.png?center=0.628252372781342,0.33766604705718484&mode=crop&width=512&height=288&rnd=133045236596970000)
Dr Richard Waugh
Bought back new procedures from overseas to Australia. Hear how he uses Lipiodol®.
Watch THE FULL VIDEO
![Prof Shin Ji Hoon](/media/2sngny5j/prof-shin-ji-hoon.png?center=0.50404370195123949,0.5006197098611056&mode=crop&width=512&height=288&rnd=133057282291800000)
Prof. Shin Ji-Hoon
He has written over 230 SCI-level theses as lead author and Lipiodol® has been mentioned and used in more than 150 of them.
![Prof. Tan Bien Soo](/media/gych2udp/prof-tan-bien-soo.png?center=0.52873563218390807,0.38929162121265437&mode=crop&width=512&height=288&rnd=133074820733670000)
Prof. Tan Bien Soo
Shares his journey as an interventional radiologist and usage of Lipiodol® in his practice.
![Prof. Chung Jin Wook](/media/pn0lqcfk/prof-chung-jin-wook.png?anchor=center&mode=crop&width=512&height=288&rnd=133110775710770000)
Prof. Chung Jin Wook
He’s been in interventional radiology for over 30 years. Hear how things has changed since then.
Guerbet celebrates its 40th anniversary
in Interventional Radiology
100 years ago, in 1921, Lipiodol® was the first iodinated contrast medium used in radiology worldwide.
A more memorable date for Guerbet Interventional Imaging was when, in 1982, 40 years ago, Guerbet revolutionized Interventional Radiology. The first transarterial treatment for liver cancer, using Lipiodol® and a cytotoxic drug mixture was performed in Japan. cTACE had just been invented.
Since that date, the development of Interventional Radiology has not ceased. Guerbet is one of the major players in this field and continues to develop solutions around the treatment of liver cancer and vascular embolization, with a range of medical drugs and devices enabling doctors globally to treat thousands of patients each day.
References
1. WEIR WC, WEIR DR., Therapeutic value of salpingograms in infertility. Fertil Steril. 1951 Nov-Dec;2(6):514-22
2. Llavallol D y Grifé A., Salpingografia de la trompa de eustaquio. Anales O.R.L. Iber.-Amer. XVII, 1990; 45-55
3. R. Sheehan et al., 1961, The Use of Lymphography as a Diagnostic Method
4. DeMaeyer, EM., Lowenstein, FW., Thilly, CH., The Control of endemic goitre, World Health Organisation, Geneva, 1979
5. Toshimitsu Konno et al., Effect of Arterial Administration of High-molecular-weight Anticancer Agent SMANCS with Lipid Lymphographic Agent on Hepatoma : a Preliminary Report*. Eur J Cancer Clin Oncol., 1983; Vol.19, No. 8, pp. 1053-1065.
6. Dreyer, K., et al., 2017. Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women. New England Journal of Medicine, 376(21), pp.2043-2052
7. Llovet J.M. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, The Lancet 2002; 359 : 1734-1739
8. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Kudo M., et al., Liver Cancer. 2021; 10:181–223.
Our Products
DRUGS & MEDICAL DEVICES